Selected research
Market Structure
Global Tumor Models Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Tumor Models market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Tumor Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Tumor Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tumor Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Tumor Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tumor Models include Labcorp, IITRI, InSphero, Biomodels, Reaction Biology, Oncodesign Services, Creative Biolabs, Abnova and Invivocue, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Tumor Models market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Tumor Models and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Tumor Models revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Tumor Models market size, projected growth trends, production technologies, key applications, and end-use industries.
Tumor Models Segment by Company
Labcorp
IITRI
InSphero
Biomodels
Reaction Biology
Oncodesign Services
Creative Biolabs
Abnova
Invivocue
Inotiv
Charles River
WuXi Biology
Tumor Models Segment by Type
Cell Line-derived Xenograft (CDX) Tumor Models
Patient-derived Xenograft (PDX) Tumor Models
Syngeneic Tumor Models
Others
Tumor Models Segment by Application
Clinical Trials
Academic Research
Others
Tumor Models Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Models market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Models and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Models.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tumor Models in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor Models industry.
Chapter 3: Detailed analysis of Tumor Models companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Modelsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cell Line-derived Xenograft (CDX) Tumor Models
- Patient-derived Xenograft (PDX) Tumor Models
- Syngeneic Tumor Models
- Others
Applications
- Clinical Trials
- Academic Research
- Others
Companies covered
- Labcorp
- IITRI
- InSphero
- Biomodels
- Reaction Biology
- Oncodesign Services
- Creative Biolabs
- Abnova
- Invivocue
- Inotiv
- Charles River
- WuXi Biology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Tumor Models Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Cell Line-derived Xenograft (CDX) Tumor Models
- 1.2.3 Patient-derived Xenograft (PDX) Tumor Models
- 1.2.4 Syngeneic Tumor Models
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Tumor Models Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Clinical Trials
- 1.3.3 Academic Research
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Tumor Models Growth Trends by Region
- 1.5.1 Global Tumor Models Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Tumor Models Market Size by Region (2021-2026)
- 1.5.3 Tumor Models Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Tumor Models Market Dynamics
- 2.1 Tumor Models Industry Trends
- 2.2 Tumor Models Industry Drivers
- 2.3 Tumor Models Industry Opportunities and Challenges
- 2.4 Tumor Models Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Tumor Models Revenue by Company (2021-2026)
- 3.2 Global Tumor Models Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Tumor Models Key Company Head office and Area Served
- 3.4 Global Tumor Models Company, Product Type & Application
- 3.5 Global Tumor Models Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Tumor Models Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Tumor Models Players Market Share by Revenue in 2025
- 3.6.3 2025 Tumor Models Tier 1, Tier 2, and Tier 3
4 Tumor Models Market by Type
- 4.1 Global Tumor Models Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Tumor Models Market Size by Type (2021-2032)
- 4.3 Global Tumor Models Market Size Share by Type (2021-2032)
5 Tumor Models Market by Application
- 5.1 Global Tumor Models Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Tumor Models Market Size by Application (2021-2032)
- 5.3 Global Tumor Models Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Labcorp
- 6.1.1 Labcorp Company Information
- 6.1.2 Labcorp Business Overview
- 6.1.3 Labcorp Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Labcorp Tumor Models Product Portfolio
- 6.1.5 Labcorp Recent Developments
- 6.2 IITRI
- 6.2.1 IITRI Company Information
- 6.2.2 IITRI Business Overview
- 6.2.3 IITRI Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 IITRI Tumor Models Product Portfolio
- 6.2.5 IITRI Recent Developments
- 6.3 InSphero
- 6.3.1 InSphero Company Information
- 6.3.2 InSphero Business Overview
- 6.3.3 InSphero Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 InSphero Tumor Models Product Portfolio
- 6.3.5 InSphero Recent Developments
- 6.4 Biomodels
- 6.4.1 Biomodels Company Information
- 6.4.2 Biomodels Business Overview
- 6.4.3 Biomodels Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Biomodels Tumor Models Product Portfolio
- 6.4.5 Biomodels Recent Developments
- 6.5 Reaction Biology
- 6.5.1 Reaction Biology Company Information
- 6.5.2 Reaction Biology Business Overview
- 6.5.3 Reaction Biology Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Reaction Biology Tumor Models Product Portfolio
- 6.5.5 Reaction Biology Recent Developments
- 6.6 Oncodesign Services
- 6.6.1 Oncodesign Services Company Information
- 6.6.2 Oncodesign Services Business Overview
- 6.6.3 Oncodesign Services Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Oncodesign Services Tumor Models Product Portfolio
- 6.6.5 Oncodesign Services Recent Developments
- 6.7 Creative Biolabs
- 6.7.1 Creative Biolabs Company Information
- 6.7.2 Creative Biolabs Business Overview
- 6.7.3 Creative Biolabs Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Creative Biolabs Tumor Models Product Portfolio
- 6.7.5 Creative Biolabs Recent Developments
- 6.8 Abnova
- 6.8.1 Abnova Company Information
- 6.8.2 Abnova Business Overview
- 6.8.3 Abnova Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Abnova Tumor Models Product Portfolio
- 6.8.5 Abnova Recent Developments
- 6.9 Invivocue
- 6.9.1 Invivocue Company Information
- 6.9.2 Invivocue Business Overview
- 6.9.3 Invivocue Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Invivocue Tumor Models Product Portfolio
- 6.9.5 Invivocue Recent Developments
- 6.10 Inotiv
- 6.10.1 Inotiv Company Information
- 6.10.2 Inotiv Business Overview
- 6.10.3 Inotiv Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Inotiv Tumor Models Product Portfolio
- 6.10.5 Inotiv Recent Developments
- 6.11 Charles River
- 6.11.1 Charles River Company Information
- 6.11.2 Charles River Business Overview
- 6.11.3 Charles River Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Charles River Tumor Models Product Portfolio
- 6.11.5 Charles River Recent Developments
- 6.12 WuXi Biology
- 6.12.1 WuXi Biology Company Information
- 6.12.2 WuXi Biology Business Overview
- 6.12.3 WuXi Biology Tumor Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 WuXi Biology Tumor Models Product Portfolio
- 6.12.5 WuXi Biology Recent Developments
7 North America
- 7.1 North America Tumor Models Market Size (2021-2032)
- 7.2 North America Tumor Models Market Size by Type
- 7.2.1 North America Tumor Models Market Size by Type (2021-2026)
- 7.2.2 North America Tumor Models Market Size by Type (2027-2032)
- 7.2.3 North America Tumor Models Market Share by Type (2021-2032)
- 7.3 North America Tumor Models Market Size by Application
- 7.3.1 North America Tumor Models Market Size by Application (2021-2026)
- 7.3.2 North America Tumor Models Market Size by Application (2027-2032)
- 7.3.3 North America Tumor Models Market Share by Application (2021-2032)
- 7.4 North America Tumor Models Market Size by Country
- 7.4.1 North America Tumor Models Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Tumor Models Market Size by Country (2021-2026)
- 7.4.3 North America Tumor Models Market Size by Country (2027-2032)
- 7.4.4 North America Tumor Models Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Tumor Models Market Size (2021-2032)
- 8.2 Europe Tumor Models Market Size by Type
- 8.2.1 Europe Tumor Models Market Size by Type (2021-2026)
- 8.2.2 Europe Tumor Models Market Size by Type (2027-2032)
- 8.2.3 Europe Tumor Models Market Share by Type (2021-2032)
- 8.3 Europe Tumor Models Market Size by Application
- 8.3.1 Europe Tumor Models Market Size by Application (2021-2026)
- 8.3.2 Europe Tumor Models Market Size by Application (2027-2032)
- 8.3.3 Europe Tumor Models Market Share by Application (2021-2032)
- 8.4 Europe Tumor Models Market Size by Country
- 8.4.1 Europe Tumor Models Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Tumor Models Market Size by Country (2021-2026)
- 8.4.3 Europe Tumor Models Market Size by Country (2027-2032)
- 8.4.4 Europe Tumor Models Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Tumor Models Market Size (2021-2032)
- 9.2 China Tumor Models Market Size by Type
- 9.2.1 China Tumor Models Market Size by Type (2021-2026)
- 9.2.2 China Tumor Models Market Size by Type (2027-2032)
- 9.2.3 China Tumor Models Market Share by Type (2021-2032)
- 9.3 China Tumor Models Market Size by Application
- 9.3.1 China Tumor Models Market Size by Application (2021-2026)
- 9.3.2 China Tumor Models Market Size by Application (2027-2032)
- 9.3.3 China Tumor Models Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Tumor Models Market Size (2021-2032)
- 10.2 Asia Tumor Models Market Size by Type
- 10.2.1 Asia Tumor Models Market Size by Type (2021-2026)
- 10.2.2 Asia Tumor Models Market Size by Type (2027-2032)
- 10.2.3 Asia Tumor Models Market Share by Type (2021-2032)
- 10.3 Asia Tumor Models Market Size by Application
- 10.3.1 Asia Tumor Models Market Size by Application (2021-2026)
- 10.3.2 Asia Tumor Models Market Size by Application (2027-2032)
- 10.3.3 Asia Tumor Models Market Share by Application (2021-2032)
- 10.4 Asia Tumor Models Market Size by Country
- 10.4.1 Asia Tumor Models Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Tumor Models Market Size by Country (2021-2026)
- 10.4.3 Asia Tumor Models Market Size by Country (2027-2032)
- 10.4.4 Asia Tumor Models Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Tumor Models Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Tumor Models Market Size by Type
- 11.2.1 South America, Middle East & Africa Tumor Models Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Tumor Models Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Tumor Models Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Tumor Models Market Size by Application
- 11.3.1 South America, Middle East & Africa Tumor Models Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Tumor Models Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Tumor Models Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Tumor Models Market Size by Country
- 11.4.1 South America, Middle East & Africa Tumor Models Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Tumor Models Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Tumor Models Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Tumor Models Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst